Roche plans $50B manufacturing expansion in US, including NJ
Roche and the pharmaceutical industry as a whole are grappling with the effects of President Donald Trump’s tariffs on imports to the U.S. Drugmaker Novartis’ also plans to spend $23 billion beefing up its U.S. operations. That includes unspecified …